Family · Pharmaceutical analytical standards
Guanfacine
An agonist of alpha-2A adrenergic receptors in the brain, approved in the United States in 1986 for hypertension and, since the late 2000s, as an extended-release form for attention deficit hyperactivity disorder (ADHD). This family brings together the active ingredient, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?Its use for disorders of the prefrontal cortex, such as ADHD, grew out of research by Amy Arnsten's laboratory at Yale University; it is not a stimulant.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
